Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huatuo Zaizao Pill for carotid atherosclerosis in ischemic stroke
ChiCTR2100041737Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of Huatuo Zaizao in ischemic stroke, atherothrombotic stroke and carotid atheroma (CAS) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Carotid plaque Crouse score. Planned start May 2021; status: not yet recruiting.
02
Drugs
Huatuo Zaizao
03
Conditions
ischemic strokeatherothrombotic strokecarotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR2100041737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041737.